Company Filing History:
Years Active: 2008
Title: Innovations in Medical Treatment by Ta-Kai Li
Introduction
Ta-Kai Li is a notable inventor based in Cupertino, CA, who has made significant contributions to the field of medical treatment. His work primarily focuses on developing compounds that address inflammation, diabetes, and related disorders. With a keen interest in improving health outcomes, Li has dedicated his research to creating effective therapeutic solutions.
Latest Patents
Li holds a patent for "Compounds for treatment of inflammation, diabetes and related disorders." This patent includes novel acyl urea, thiourea, carbamate, thiocarbamate, and related compounds that are effective in inhibiting the cytokine-mediated inflammatory response in cultured cells. These compounds have shown promise in ameliorating bone destruction in animal models of arthritis and in lowering blood glucose levels in animal models of Type II diabetes mellitus. The compounds are disclosed as useful for a variety of treatments, including diabetes mellitus, insulin resistance, inflammation, inflammatory diseases, immunological diseases, and cancer. He has 1 patent to his name.
Career Highlights
Ta-Kai Li is currently associated with Theracos, Inc., where he continues to innovate and develop new therapeutic compounds. His work has the potential to significantly impact the treatment of various medical conditions, making him a valuable asset in the field of medical research.
Collaborations
Li collaborates with esteemed colleagues such as Partha Neogi and Debedranath Dey, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Ta-Kai Li's contributions to medical treatment through his innovative compounds highlight the importance of research in addressing critical health issues. His work exemplifies the potential of scientific advancements to improve patient care and outcomes.